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Background: Cytomegalovirus (CMV) is known to be a 
significant cause of morbidity and mortality following blood 
transfusion in children and immunocompromised adults. In Sudan, it 
is not mandatory to screen donated blood for CMV in blood banks. 
Very few studies have been conducted in Sudan to estimate the 
seroprevalence of this infection in voluntary blood donors. 
Aim: The goal of this study was to estimate the seroprevalence 
of Cytomegalovirus among blood donors attending Omdurman 
Teaching Hospital Blood Bank, Omdurman- Khartoum State–Sudan. 
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Methods: Ninety males (90) voluntary blood donors’ sera were 
collected and analyzed for detecting CMV IgG and IgM antibodies by 
Enzyme linked immunosorbent assay (ELISA). 
Result: Out of 90 voluntary blood donors tested, 82 (91.1%) 
were seropositive for CMV IgG and 12 (13.3%) were positive for CMV 
IgM and, the overall seroprevalence was 93.3%. The result showed 
highest seroprevalence (37.8% for IgG) among group age (25-31) year. 
There was no statistically significant difference in seropositivity of 
CMV based on distribution of age. 
Conclusion: Since about 93.3% of blood donors in Sudan are 
seropositive for CMV, it would seem redundant to screen blood donors 
for CMV, as very few seronegative blood units would be available for 
transfusion. Other preventive strategies, such as leuko-reduction, etc., 
could be more appropriate and cost-effective for the prevention of 
transmission of CMV through infected blood to immunosuppressed 
individuals. 
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Cytomegalovirus (CMV) is a member of β-Herpesviridae family. 
It is the largest member (150-200nm) of the family and it 
cannot be differentiated from other members morphologically.1 
This pathogenic virus has a widespread distribution and can 
infect individuals at any age.1 Acute primary infection in the 
immunecompetent children and adult is self-limiting, followed 
by virus latency in CD34+ haemopoietic progenitor cell in bone 
marrow and CD13+; CD14+ peripheral blood monocytes.2 The 
virus has the ability to enter latency after asymptomatic 
infection in immunocompetent individuals.3 Transfusion-
transmitted cytomegalovirus infection is associated with 
considerable morbidity and mortality in at risk populations 
such as AIDS patients, CMV seronegative neonates and organ 
transplant recipients.3 CMV infection is widespread in 
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developing countries and areas where socio-economic conditions 
are poor.3 CMV is one of the most common causes of congenital 
malformations resulting from viral intrauterine infection in 
developed countries.4  The prevalence of CMV tends to be lower 
in developed countries than in developing countries.5 CMV is a 
globally-occurring infection with a high prevalence (50-90%) in 
all human populations.6 In developing countries, the rates are 
generally higher, and the infection is acquired at younger age.6 
Virus transmission occurs via body fluids (blood, saliva, breast 
milk, semen, and cervical secretions), and since the virus is 
labile, intimate contact with a person with primary or 
reactivated infection is needed.6 Therefore, transmission mainly 
occurs within families, between sex partners, and in groups of 
small children.6 Children acquiring CMV at a pre-school age 
shed the virus for extended period and therefore constitute a 
major societal reservoir of virus. 6 The description of 
cytomegalovirus transmission by blood transfusion and body 
fluids has provoked a greatly heightened emphasis on two 
fundamental objectives: safety and protection of human life.7 
Transfusion transmissible infections (TTIs) are a very serious 
complication of blood transfusion.7 These infections continue to 
pose a great challenge to transfusion medicine, especially in 
Africa, due to a high transfusion demand.7 The aim of this 
study was to estimate the seroprevalence of Cytomegalovirus 
Immunoglobulin G (IgG) and immunoglobulin M (IgM) among 
voluntary blood donors at Omdurman Teaching Hospital Blood 
Bank. 
 
Materials and Methods 
 
Study design: 
This is a descriptive across-sectional study, consisted of 90 
males voluntary blood donors aged between (18-50) years old 
with mean age 26.7 years old, conducted during March 2015 at 
Omdurman Teaching Hospital Blood Bank, Omdurman-Sudan. 
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Sampling: 
Three (3) milliliters of blood samples were collected from ninety 
(90) males blood donors and the sera were separated and stored 
at -20 C° until analysis.  
 
The inclusion criteria: 
Donors age was between 18 and 50 years; weight >45 kg; 
hemoglobin >12.5g/dl; normal blood pressure (BP), pulse, and 
temperature. Not belonging to any high-risk group, and no 
history of any severe current or chronic illnesses. 
 
Ethical consideration: 
Ethical clearance was obtained from the hospital’s research and 
ethics committee. 
 
Processing of the samples: 
All sera were tested for IgM and IgG CMV by the Enzyme 
Linked Immunosorbent Assay (ELISA) test. The CMV-specific 
IgM/IgG antibodies were analyzed by the commercial (Chemux 
BioScience, Inc.USA) according to the manufacturer’s 
instructions. 
The serum samples and kits components were brought 
at room temperature, all samples, calibrators, negative and 
positive controls were diluted at the ratio 1:40 by taking 5µl of 
sample with 200 of the sample diluent. 100µl of diluted 
samples, and calibrators and controls were added into each of 
CMV antigen coated wells except for A1 well which is used for 
blank by adding 100µl of sample diluent, and incubated at room 
temperature for 30 minutes, after washing three times,100µl of 
the enzyme conjugate was added into each well, and incubated 
at room temperature for 30 minutes, after washing the TMB 
chromogen was added into each well, after 15 minutes of 
incubation stop solution (sulphuric acid) was added into each 
well. And the optical densities (O.D.) have been read using 
ELISA microwell plate reader at filter of 450 nm.  
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Calculation of IgG was by dividing the sample O.D. by the 
mean of two cut-off calibrators O.D. 
CMV IgM index of each determination was by dividing 
the O.D values of each sample by cut-off calibrator O.D. value. 
 
Interpretation: IgG and IgM 
Negative: CMV IgG index of 0.90 or less are 
seronegative for IgG antibody to CMV (<1.1IU/mL) 
Equivocal: CMV IgG index of 0.91-0.99 or less are 
equivocal sample should be retested. 
Positive: CMV IgG index of 1.00 or greater or IU value 
greater than 1.2 are seropositive, it indicate prior exposure to 
the CMV virus (>1.2 IU/mL) 




All of the ninety (90) healthy individuals selected for blood 
donation were males. The mean age of the individuals was 26.7 
years (age range 18-50 years). Seropositivity was 82 (91.1%) 
and 12 (13.3 %) for CMV-IgG and CMV-IgM antibodies 
respectively. There was no statistically significant difference (p 
> 0.05) in the CMV IgG status in different age group. The result 
showed highest seroprevalence (37.8% for IgG) among age 
group (25-31 year) - Table.1 
 















18- 24 26 (28.9%) 24 (29.3%) 2 (25%) 3 (25%) 23 (29.5%) 26 
25-31 34 (37.8%) 29 (35.4%) 5 (62.5%) 4 (33.3) 30 (38.5%) 34 
32-38 13 (14.4%) 13 (15.9%) 0 (0%) 2 (16.7%) 11(14.1%) 13 
39-45 11 (12.2%) 11 (13.4%) 0 (0%) 3 (25%) 8 (10.2%) 11 
46-52 6 (6.7%) 5 (6.0%) 1 (12.5%) 0 (0%) 6 (7.7%) 6 
Total 82 (100%) 82 (100%) 8 (100%) 12 (100%) 78 (100%) 90 
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Figure 1 Anti-CMV IgG Prevalence 
 
 






Due to the ubiquity of Cytomegalovirus and the risk of 
transmitting the virus through blood transfusion; several 
researches have been conducted in various countries among 
blood donors for detecting the prevalence of Cytomegalovirus 
antibodies, few studies have been conducted in Sudan. 
This study results revealed that 91.1%, 13.3 were 
positive for Cytomegalovirus IgG and IgM antibodies 
respectively, The results showed an overall prevalence rate of 
91.1% of CMV IgG suggestive of ubiquitous past exposure to 
infection. And prevalence rate of IgM was 13.3%. 
When compared with other studies were found similar to 
(97% and 96%) reported in Tunisia and India, respectively. 8-9 
However, the results showed high prevalence compared to those 
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reported among Sudanese blood donors (77%).10 The high 
prevalence rate indicates the endemicity of infection, and this 
perhaps could be related to socio-economic, environmental, and 
climatic factors.11 
The high prevalence rates observed in these countries 
contradict those of western nations which ranged from 38% to 
75%.12 Also it was related to results obtained as high as 90% 
has been recorded in Japan and Hong Kong; countries that are 
not regarded as developing nations.13 Seroprevalence for CMV 
IgM antibody was found to be 13.3% representing the 
percentage of those that had active infection. Previous studies 
have reported rates of 0% and 19.5% in Ghana and Nigeria, 
respectively.14-15  
It has been argued that CMV IgM positive blood is more 
infective than IgG positive blood.16 
And in this study it showed the highest prevalence of 




There is high seroprevalence of anti-CMV IgG antibodies 
among the blood donors than the anti-CMV IgM antibodies, 
which is an indication of previous infections by the virus. And 
the presence of Immunoglobulin M to Cytomegalovirus suggests 
the presence of active infection. Strategies for protecting high 
risk individual are recommended, like screening blood for 
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